[
THE INVESTOR] As of Feb. 21 09:55 A.M., WhaninPharm increased 1.05%, compared with yesterday, to 14,500 won. It had declined 5.54% through the past month. Standard deviation, the variableness index, was 1.2% on the same period over one month.
Compared with its close competitors within the same industry, KOSPI, since the monthly volatility of WhaninPharm was the lowest, the earnings rate over one month was also relatively lower than that of its peer group's. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -4.6%. Compared with the KOSPI industry, the return-on-risk is below the industrial mean, 1.8, and thus the industrial comparison performance was not so good.
By HeRo (
hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.